Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Phospho-Cdc5L (Tyr232) Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5105338
Description
Antibody detects endogenous levels of CDC5L only when phosphorylated at Tyr232.
The protein encoded by this gene shares a significant similarity with Schizosaccharomyces pombe cdc5 gene product, which is a cell cycle regulator important for G2/M transition. This protein has been demonstrated to act as a positive regulator of cell cycle G2/M progression. It was also found to be an essential component of a non-snRNA spliceosome, which contains at least five additional protein factors and is required for the second catalytic step of pre-mRNA splicing.
Specifications
| Phospho-Cdc5L (Tyr232) | |
| Polyclonal | |
| Unconjugated | |
| CDC5L | |
| 1200002I02Rik; AA408004; CDC5; CDC5 cell division cycle 5-like; CDC5 cell division cycle 5-like (S. pombe); CDC5L; CDC5-LIKE; Cdc5-like protein; Cdc5-related protein; CEF1; cell division cycle 5 like; cell division cycle 5-like; cell division cycle 5-like (S. pombe); cell division cycle 5-like protein; cell division cycle 5-related protein; dJ319D22.1; dJ319D22.1 (CDC5-like protein); hCDC5; KIAA0432; Pcdc5rp; Pombe cdc5-related protein; Unknown (protein for MGC:128482); zgc:55853 | |
| Rabbit | |
| Sequential chromatography | |
| RUO | |
| 71702, 85434, 988 | |
| -20°C | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| O08837, Q6A068, Q99459 | |
| CDC5L | |
| A synthesized peptide derived from human CDC5L(Accession Q99459), corresponding to amino acid residues around phosphorylated Tyr232. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction